Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_assertion description "[To test this notion, frequency of single nucleotide polymorphisms (SNPs; n = 42) within predicted miRNA binding sites or miRNA precursors were determined and compared in 363 BRCA1 mutation carriers: asymptomatic (n = 160), breast cancer (n = 140) and ovarian cancer (n = 63) patients, and in 125 BRCA2 mutation carriers: asymptomatic (n = 48), breast cancer (n = 58) and ovarian cancer (n = 19) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_assertion evidence source_evidence_literature NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_assertion SIO_000772 19950226 NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_assertion wasDerivedFrom befree-2016 NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_assertion wasGeneratedBy ECO_0000203 NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.
- befree-2016 importedOn "2016-02-19" NP778542.RA6eFpMKo7qKxVQxRuQa1eeGrkd98du7K_mx7nAuHZ6iI130_provenance.